Results 311 to 320 of about 303,204 (352)
Some of the next articles are maybe not open access.
Preclinical Evaluation of Neuraxial Drugs for Safety
2023Tony L. Yaksh +2 more
openaire +1 more source
Evaluation of Antiseptic Drug Candidate Pyridosept in Preclinical in Vitro Studies
Current Medicinal ChemistryIntroduction: This work provides preclinical in vitro studies of an innovative antimicrobial agent named pyridosept, belonging to the quaternary bis-ammonium salts and synthesized on the base of pyridoxine. Since the wide spread of pathogens with tolerance to both antibiotics and antiseptics challenges the ...
Renata Kazakova +20 more
openaire +2 more sources
Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies
Ca-A Cancer Journal for Clinicians, 2022Paolo Tarantino +2 more
exaly
Human malignant melanoma: preclinical and clinical drug evaluation.
Behring Institute Mitteilungen, 1984A panel of 17 melanoma xenograft lines was exposed to various DNA reactive agents. Growth delay values were calculated from tumor volume responses of xenograft bearing mice and correlated with donor patient's response as determined by standard clinical criteria.
openaire +1 more source
Cancer epigenetics in clinical practice
Ca-A Cancer Journal for Clinicians, 2023Veronica Davalos, Manel Esteller
exaly
Treatment of muscle‐invasive and advanced bladder cancer in 2020
Ca-A Cancer Journal for Clinicians, 2020Vaibhav G Patel +2 more
exaly
Preclinical evaluation of anti-CD269 antibody–drug conjugates
European Journal of Cancer, 2016A. Palfi +5 more
openaire +1 more source
An update on the immune landscape in lung and head and neck cancers
Ca-A Cancer Journal for Clinicians, 2020Jennifer W Carlisle +2 more
exaly